BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25663675)

  • 1. Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
    Tzatzarakis MN; Vakonaki E; Kovatsi L; Belivanis S; Mantsi M; Alegakis A; Liesivuori J; Tsatsakis AM
    J Anal Toxicol; 2015 May; 39(4):313-20. PubMed ID: 25663675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine and nor-buprenorphine levels in head hair samples from former heroin users under Suboxone® treatment.
    Belivanis S; Tzatzarakis MN; Vakonaki E; Kovatsi L; Mantsi M; Alegakis A; Kavvalakis MP; Vynias D; Tsatsakis AM
    Drug Test Anal; 2014 Jun; 6 Suppl 1():93-100. PubMed ID: 24817054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of buprenorphine, norbuprenorphine, naloxone, and their glucuronides in urine by liquid chromatography-tandem mass spectrometry.
    Mariottini C; Gergov M; Ojanperä I
    Drug Test Anal; 2021 Sep; 13(9):1658-1667. PubMed ID: 34047070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.
    Concheiro M; Shakleya DM; Huestis MA
    Forensic Sci Int; 2009 Jul; 188(1-3):144-51. PubMed ID: 19406593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.
    Concheiro-Guisan M; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2009 May; 394(2):513-22. PubMed ID: 19247639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.
    Kacinko SL; Concheiro-Guisan M; Shakleya DM; Huestis MA
    Anal Bioanal Chem; 2008 Nov; 392(5):903-11. PubMed ID: 18758763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine and norbuprenorphine findings in hair during constant maintenance dosage.
    Skopp G; Kniest A; Haisser J; Mann K; Hermann D
    Int J Legal Med; 2011 Mar; 125(2):277-81. PubMed ID: 21301858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online solid-phase extraction liquid chromatography-electrospray-tandem mass spectrometry analysis of buprenorphine and three metabolites in human urine.
    Liu AC; Lin TY; Su LW; Fuh MR
    Talanta; 2008 Mar; 75(1):198-204. PubMed ID: 18371868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-beta-D-glucuronide and norbuprenorphine-3-beta-D-glucuronide in human plasma.
    Murphy CM; Huestis MA
    J Mass Spectrom; 2005 Jan; 40(1):70-4. PubMed ID: 15637731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
    Concheiro M; Jones H; Johnson RE; Shakleya DM; Huestis MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):13-20. PubMed ID: 19945361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment.
    Kacinko SL; Jones HE; Johnson RE; Choo RE; Concheiro-Guisan M; Huestis MA
    Clin Chem; 2009 Jun; 55(6):1177-87. PubMed ID: 19325013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid quantification of buprenorphine-glucuronide and norbuprenorphine-glucuronide in human urine by LC-MS-MS.
    Hegstad S; Khiabani HZ; Øiestad EL; Berg T; Christophersen AS
    J Anal Toxicol; 2007 May; 31(4):214-9. PubMed ID: 17555645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair analysis for long-term monitoring of buprenorphine intake in opiate withdrawal.
    Pirro V; Fusari I; Di Corcia D; Gerace E; De Vivo E; Salomone A; Vincenti M
    Ther Drug Monit; 2014 Dec; 36(6):796-807. PubMed ID: 24713865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nonhydrolysis and hydrolysis methods for the determination of buprenorphine metabolites in urine by liquid chromatography-tandem mass spectrometry.
    Al-Asmari AI; Anderson RA
    J Anal Toxicol; 2008; 32(9):744-53. PubMed ID: 19021929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples.
    Favretto D; Frison G; Vogliardi S; Ferrara SD
    Rapid Commun Mass Spectrom; 2006; 20(8):1257-65. PubMed ID: 16550495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simplified processing and rapid quantification of buprenorphine, norbuprenorphine, and their conjugated metabolites in human plasma using UPLC-MS/MS: Assessment of buprenorphine exposure during opioid use disorder treatment.
    Zhao W; Alshogran OY; Zhang H; Joshi A; Krans EE; Caritis S; Shaik IH; Venkataramanan R
    J Mass Spectrom; 2024 Apr; 59(4):e5015. PubMed ID: 38501738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine is superior to oral fluid for detecting buprenorphine compliance in patients undergoing treatment for opioid addiction.
    Ransohoff JR; Petrides AK; Piscitello GJ; Flood JG; Melanson SEF
    Drug Alcohol Depend; 2019 Oct; 203():8-12. PubMed ID: 31394416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine naloxone concentration at different phases of buprenorphine maintenance treatment.
    Heikman P; Häkkinen M; Gergov M; Ojanperä I
    Drug Test Anal; 2014 Mar; 6(3):220-5. PubMed ID: 23512803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.